Oncology & Specialty

Kalyani, India

Located near Kolkata, India, our Kalyani facility combines scientific expertise, advanced manufacturing technologies, and a strong regulatory track record in oncology and specialty APIs.

Supported by successful inspections and approvals from major European and international regulatory authorities, the site delivers reliable and compliant solutions for global markets.

Through integrated CDMO services and dedicated high-potency capabilities, we support customers from development and scale-up to commercial supply.

Why Fresenius Kabi

Regulatory Excellence

Successful European and international inspections
Proven compliance track record
Global market support

Oncology & Specialty APIs

Commercial and pipeline portfolio
High-potency capabilities
Scientific and process expertise

Manufacturing Platform

Multipurpose and dedicated facilities
ISO 8 production areas
Scalable GMP manufacturing

Integrated CDMO Services

Development and scale-up
Analytical support
Commercial supply solutions

Our API Portfolio

Oncology

Commercially available

Azacitidine
Bendamustine
Busulfan
Carboplatin
Cisplatin
Decitabine
Docetaxel
Gemcitabine
Irinotecan
Oxaliplatin
Paclitaxel
Pemetrexed

R&D

Afatinib
Alectinib
Carfilzomib
Ibrutinib
Ribociclib

Specialty

Local Anesthetics

Levobupivacaine
Bupivacaine
Ropivacaine

Complex & Specialty Molecules

Sugammadex

APIs available upon evaluation

Oncology

Cabazitaxel
Anastrozole
Letrozole
Bicalutamide
Plerixafor
Imatinib
Pralatrexate
Leucovorin

Specialty

Remimazolam
Chloramphenicol

End-to-End CDMO Solutions

From process development to commercial supply

We provide integrated CDMO services across the full API lifecycle, supporting process development, scale-up, GMP manufacturing, analytical services and regulatory support.

With advanced manufacturing technologies and dedicated high-potency capabilities, we help customers bring complex molecules to market efficiently and reliably.